Molecular Rescue of Dyrk1A Overexpression Alterations in Mice with Fontup® Dietary Supplement: Role of Green Tea Catechins
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Rescue of Dyrk1A Overexpression Alterations in Mice with Fontup® Dietary Supplement: Role of Green Tea Catechins
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 4, Pages 1404
Publisher
MDPI AG
Online
2020-02-20
DOI
10.3390/ijms21041404
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LPS-Induced Inflammation Abolishes the Effect of DYRK1A on IkB Stability in the Brain of Mice
- (2018) Alizée Latour et al. MOLECULAR NEUROBIOLOGY
- Green Tea Catechins Effectively Altered Hepatic Fibrogenesis in Rats by Inhibiting ERK and Smad1/2 Phosphorylation
- (2018) Liwen Wang et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Green Tea Polyphenol Epigallocatechin-3-gallate Suppresses Toll-like Receptor 4 Expression via Up-regulation of E3 Ubiquitin-protein Ligase RNF216
- (2017) Motofumi Kumazoe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ameliorative effect of Epigallocatechingallate on cardiac hypertrophy and fibrosis in Aged rat
- (2017) Ibrahim Muhammed et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Blood-Brain Barrier Permeability of Green Tea Catechin Metabolites and their Neuritogenic Activity in Human Neuroblastoma SH-SY5Y Cells
- (2017) Keiko Unno et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes
- (2017) Megan Stringer et al. PHYSIOLOGY & BEHAVIOR
- Aerobic exercise and a BDNF-mimetic therapy rescue learning and memory in a mouse model of Down syndrome
- (2017) Martina Parrini et al. Scientific Reports
- Impact of Dyrk1A level on alcohol metabolism
- (2016) Marjorie Renon et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial
- (2016) Rafael de la Torre et al. LANCET NEUROLOGY
- Differential effects of Epigallocatechin-3-gallate containing supplements on correcting skeletal defects in a Down syndrome mouse model
- (2016) Irushi Abeysekera et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome
- (2016) Fiorenza Stagni et al. NEUROSCIENCE
- DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome
- (2016) Arnaud Duchon et al. Frontiers in Behavioral Neuroscience
- Vinardo: A Scoring Function Based on Autodock Vina Improves Scoring, Docking, and Virtual Screening
- (2016) Rodrigo Quiroga et al. PLoS One
- High doses of (−)-epigallocatechin-3-gallate from green tea induces cardiac fibrosis in mice
- (2015) Yi Cai et al. BIOTECHNOLOGY LETTERS
- Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model
- (2015) Megan Stringer et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Pharmacological correction of excitation/inhibition imbalance in Down syndrome mouse models
- (2015) Benoit Souchet et al. Frontiers in Behavioral Neuroscience
- Principal Component Analysis of the Effects of Environmental Enrichment and (-)-epigallocatechin-3-gallate on Age-Associated Learning Deficits in a Mouse Model of Down Syndrome
- (2015) Silvina Catuara-Solarz et al. Frontiers in Behavioral Neuroscience
- Prefrontal Deficits in a Murine Model Overexpressing the Down Syndrome Candidate Gene Dyrk1a
- (2014) A. Thomazeau et al. JOURNAL OF NEUROSCIENCE
- Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations
- (2014) Katheleen Gardiner Drug Design Development and Therapy
- A high-performance liquid chromatography assay for Dyrk1a, a Down syndrome-associated kinase
- (2013) Linh C. Bui et al. ANALYTICAL BIOCHEMISTRY
- Lessons Learned in Empirical Scoring with smina from the CSAR 2011 Benchmarking Exercise
- (2013) David Ryan Koes et al. Journal of Chemical Information and Modeling
- Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans
- (2013) Rafael De la Torre et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Environmental enrichment rescues DYRK1A activity and hippocampal adult neurogenesis in TgDyrk1A
- (2013) Meritxell Pons-Espinal et al. NEUROBIOLOGY OF DISEASE
- Form follows function: BDNF and its involvement in sculpting the function and structure of synapses
- (2013) Marta Zagrebelsky et al. NEUROPHARMACOLOGY
- Green tea extract: A potential cause of acute liver failure
- (2013) Shreena S Patel WORLD JOURNAL OF GASTROENTEROLOGY
- Epicatechin-3-O-(3″-O-methyl)-gallate Content in Various Tea Cultivars (Camellia sinensis L.) and Its in Vitro Inhibitory Effect on Histamine Release
- (2012) Mari Maeda-Yamamoto et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Dyrk1A, a Serine/Threonine Kinase, is Involved in ERK and Akt Activation in the Brain of Hyperhomocysteinemic Mice
- (2012) Sabiha Abekhoukh et al. MOLECULAR NEUROBIOLOGY
- Down syndrome: the brain in trisomic mode
- (2012) Mara Dierssen NATURE REVIEWS NEUROSCIENCE
- DYRK1A: A master regulatory protein controlling brain growth
- (2012) Fayçal Guedj et al. NEUROBIOLOGY OF DISEASE
- Identification of novel candidate maternal serum protein markers for Down syndrome by integrated proteomic and bioinformatic analysis
- (2012) Yuan Kang et al. PRENATAL DIAGNOSIS
- PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKaPredictions
- (2011) Mats H. M. Olsson et al. Journal of Chemical Theory and Computation
- Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases
- (2011) Masahito Shimizu et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Biological actions of green tea catechins on cardiac troponin C
- (2010) Naoto Tadano et al. BRITISH JOURNAL OF PHARMACOLOGY
- MNB/DYRK1A as a multiple regulator of neuronal development
- (2010) Francisco J. Tejedor et al. FEBS Journal
- Activation, regulation, and inhibition of DYRK1A
- (2010) Walter Becker et al. FEBS Journal
- Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations
- (2010) Debra Toiber et al. NEUROBIOLOGY OF DISEASE
- Hyperhomocysteinemia-induced Dyrk1a downregulation results in cardiomyocyte hypertrophy in rats
- (2009) Lamia Raaf et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
- (2009) Oleg Trott et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Green Tea Polyphenols Rescue of Brain Defects Induced by Overexpression of DYRK1A
- (2009) Fayçal Guedj et al. PLoS One
- DYRK1A, a Novel Determinant of the Methionine-Homocysteine Cycle in Different Mouse Models Overexpressing this Down-Syndrome-Associated Kinase
- (2009) Christophe Noll et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search